ReviewCancer diagnosis & prognosis

Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.

Vasileios Papanikolaou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.